An Open-label, Multi-centre Post-marketing Study to Assess the Efficacy and Safety of Voncento in Subjects with Von Willebrand Disease

Trial Profile

An Open-label, Multi-centre Post-marketing Study to Assess the Efficacy and Safety of Voncento in Subjects with Von Willebrand Disease

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Feb 2017

At a glance

  • Drugs Von Willebrand factor (Primary)
  • Indications Von Willebrand disease
  • Focus Therapeutic Use
  • Sponsors CSL Behring
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 24 Oct 2015 Status changed from not yet recruiting to recruiting as per European Clinical Trials Database record.
    • 25 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top